Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome

被引:62
作者
Wentworth, PA
Sette, A
Celis, E
Sidney, J
Southwood, S
Crimi, C
Stitely, S
Keogh, E
Wong, NC
Livingston, B
Alazard, D
Vitiello, A
Grey, HM
Chisari, FV
Chesnut, RW
Fikes, J
机构
[1] RW JOHNSON PHARMACEUT RES INST, SAN DIEGO, CA 92121 USA
[2] LA JOLLA INST ALLERGY & IMMUNOL, LA JOLLA, CA 92037 USA
[3] SCRIPPS RES INST, LA JOLLA, CA 92037 USA
关键词
A2; cytotoxic T lymphocyte; epitope; hepatitis C virus;
D O I
10.1093/intimm/8.5.651
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have focused on conserved regions of the hepatitis C Virus (HCV) genome to identify viral peptides that contain HLA class I binding motifs and bind with high affinity to the corresponding purified HLA molecules, Accordingly, we have identified 31 candidate epitopes in the HCV that have the potential to be recognized by either HLA-A1-, A2.1-, A3-, A11- or A24-restricted cytotoxic T lymphocytes (CTL), Twelve conserved peptides that bind HLA-A2.1 with high or intermediate affinity were tested for immunogenicity in vitro in human primary CTL cultures and in vivo by direct immunization of HLA-A2.1/K-b transgenic mice, Six HLA-A2.1-restricted CTL epitopes were immunogenic in both systems, At least three of these peptide epitopes were endogenously processed and presented for CTL recognition. Overall, these data illustrate the value of this approach for the development of virus-specific, peptide-based vaccines.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 74 条
  • [1] ANTIVIRAL CYTOTOXIC T-CELL RESPONSE INDUCED BY INVIVO PRIMING WITH A FREE SYNTHETIC PEPTIDE
    AICHELE, P
    HENGARTNER, H
    ZINKERNAGEL, RM
    SCHULZ, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) : 1815 - 1820
  • [2] ALTER HJ, 1989, CURRENT PERSPECTIVES, P83
  • [3] THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES
    ALTER, MJ
    MARGOLIS, HS
    KRAWCZYNSKI, K
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    GERBER, MA
    SAMPLINER, RE
    MEEKS, EL
    BEACH, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1899 - 1905
  • [4] ATTEGAY M, 1994, 2 INT M HEP C REL VI
  • [5] PATIENTS WITH CHRONIC HEPATITIS-C HAVE CIRCULATING CYTOTOXIC T-CELLS WHICH RECOGNIZE HEPATITIS-C VIRUS-ENCODED PEPTIDES BINDING TO HLA-A2.1 MOLECULES
    BATTEGAY, M
    FIKES, J
    DIBISCEGLIE, AM
    WENTWORTH, PA
    SETTE, A
    CELIS, E
    CHING, WM
    GRAKOUL, A
    RICE, CM
    KUROKOHCHI, K
    BERZOFSKY, JA
    HOOFNAGLE, JH
    FEINSTONE, SM
    AKATSUKA, T
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2462 - 2470
  • [6] INDUCTION OF OVALBUMIN-SPECIFIC CYTO-TOXIC T-CELLS BY INVIVO PEPTIDE IMMUNIZATION
    CARBONE, FR
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) : 603 - 612
  • [7] CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF
    CERNY, A
    MCHUTCHISON, JG
    PASQUINELLI, C
    BROWN, ME
    BROTHERS, MA
    GRABSCHEID, B
    FOWLER, P
    HOUGHTON, M
    CHISARI, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) : 521 - 530
  • [8] Cerny A, 1994, Curr Top Microbiol Immunol, V189, P169
  • [9] CERNY A, 1994, 2 INT M HEP C REL VI
  • [10] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362